Venatorx Pharmaceuticals Named ‘Best Places to Work’ Third Year in a Row
Venatorx Pharmaceuticals announced that it was named one of the “2020 Best Places to Work” in the medium-sized company category in the Greater Philadelphia area by the Philadelphia Business Journal.
HR Technology News: DHGE Launches Resilience Program for COVID-19 Frontline Workers
Proud to be named @PHLBizJournal #BestPlacesToWork for the 3rd year in a row! We are grateful to our team for their unwavering commitment to bring lifesaving #antibiotics and #antivirals to patients around the globe!! #innovation #BPTW2020
The Philadelphia Business Journal, in partnership with Quantum Workplace, honors companies based on a scoring benchmark, which reflects employee response rates as well as employee rankings of work environment, people, personal growth, and professional development. Quantum Workplace employee surveys measure each company’s culture, from compensation and benefits to trust in senior leadership.
HR Technology News: Terminal Named a Best Place to Work by Inc. Magazine
“This year marks Venatorx’s 10th Anniversary. Being named a ‘Best Places to Work’ for the third year in a row comes at a fitting time to acknowledge our team’s unwavering commitment to bring lifesaving antibiotics and antiviral medicines to patients around the globe,” said Christopher J. Burns, Ph.D., President and CEO of Venatorx. “The COVID-19 pandemic has tested our will and presented strenuous and challenging environments through which our team continues to demonstrate mutual respect, steadfast determination and exceptional resilience. We are honored by this recognition and grateful to our employees for being ambassadors of our mission.”
Headquartered in the suburbs of Philadelphia, Venatorx has grown from three founders in 2010 to over 70 employees in 2020 and is actively seeking driven, passionate and entrepreneurial-minded professionals for open positions in CMC, Regulatory Affairs, Operations, Discovery, and Development to support its aggressive strategic growth plan.